← SynDRA
BEDAQUILINE
SynDRA canonical compound SYN0006795 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | ATPase inhibitor |
| Indication | tuberculosis |
| Disease area | infectious disease |
All known targets
- KCNH2
- MycB Prop
- atpA
- atpB
- atpC
- atpD
- atpE
- atpF
- atpFH
- atpG
Mechanisms of action (all sources)
- ATPase inhibitor
- MycB Prop MODULATOR
- atpE INHIBITOR
- atpD INHIBITOR
- atpA INHIBITOR
- atpG INHIBITOR
- atpC INHIBITOR
- atpFH INHIBITOR
- atpF INHIBITOR
- atpB INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HTR2A
- ACHE
- ADORA1
- HMBS
- HRH1
- HRH3
- HTR1A
- HTR2B
- MAOA
- MC3R
- NR1I2
- OPRM1
- PDE3A
- PDE4A
- PDE4D
- PGR
- PTGS1
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HDAC6
- FECH
- F2
- CHRM2
- ADORA2A
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2C
- ADRB2
- AR
- CHRM1
- CHRNA4
- ESR1
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ADCY9
- CIB1
- CP2C9
- CP2D6
- CP3A7
- GPR151
- KSYK
- NSD2
- SYK
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
- Antitubercular Agents
- Diarylquinoline Antimycobacterial
ATC classes
- J04A · DRUGS FOR TREATMENT OF TUBERCULOSIS
Cross-references
Synonyms
- SIRTURO
- Sirturo
- sirturo
- TMC207
- bedaquiline fumarate
- Bedaquilina
- R-207910
- R207910
- TMC-207
- SIRTURO (TN)
- R 207910
- TMC 207
- bedaquilina
- bedaquilinum
- AIDS 222089
- CHEBI:72292
- RefChem:56885
- J04AK05
- DTXCID501331924
- (alphaR,betaS)-rel-Bedaquiline
- Bedaquiline [USAN:INN]
- HSDB 8217
- UNII-78846I289Y
- C32H31BrN2O2
- MMV689758
- (aS,bR)-Bedaquiline
- MFCD22628872
- BDQ
- Bedaquiline [USAN]
- BQ1
- Bedaquiline (Standard)
- BEDAQUILINE [MI]
- BEDAQUILINE [INN]
- (aR,bS)-rel-Bedaquiline
- Bedaquiline (USAN/INN)
- BEDAQUILINE [VANDF]
- (alphaS,betaR)-Bedaquiline
- BEDAQUILINE [WHO-DD]
Look up BEDAQUILINE in the interactive SynDRA portal →